Medicare Enrolled

Dr. Miguel Ortiz-Bonilla, MD

Pulmonary Disease · Kissimmee, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3480 POLYNESIAN ISLE BLVD, Kissimmee, FL 34746
4075072615
In practice since 2014 (12 years)
NPI: 1366869422 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ortiz-Bonilla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ortiz-Bonilla? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ortiz-Bonilla

Dr. Miguel Ortiz-Bonilla is a pulmonary disease in Kissimmee, FL, with 12 years in practice. Based on federal Medicare data, Dr. Ortiz-Bonilla performed 1,326 Medicare services across 706 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ortiz-Bonilla received a total of $7,079 from 37 pharmaceutical and/or device companies across 168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ortiz-Bonilla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice▲ Top 45% volume in FL$ $7,079 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,326
Medicare services
Top 45% in FL for pulmonary disease
706
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~110 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity815$94$231
Critical care, first 30-74 min158$168$746
Initial hospital admission, high complexity149$136$388
Office visit, established patient (30-39 min)70$98$215
Hospital follow-up visit, moderate complexity38$63$160
Aspiration of fluid from chest cavity using imaging guidance31$84$511
Irrigation and suction of lung airways to obtain cells using an endoscope20$100$348
Test to measure expiratory airflow and volume15$21$73
Test to determine lung volumes using sensors15$41$109
Test to examine how well the lungs exchange gases15$43$108
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,079
Total received (2018-2024)
Avg $1,180/year across 6 years
Top 29% in FL for pulmonary disease
37
Companies
168
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,079 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,498
2023
$2,162
2022
$2,258
2021
$913
2019
$223
2018
$25

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,732
GlaxoSmithKline, LLC.
$839
Actelion Pharmaceuticals US, Inc.
$609
Regeneron Healthcare Solutions, Inc.
$570
Boehringer Ingelheim Pharmaceuticals, Inc.
$435
Grifols USA, LLC
$302
United Therapeutics Corporation
$290
Cook Medical LLC
$261
Pulmonx Corporation
$141
La Jolla Pharmaceutical Company
$129
Axsome Therapeutics, Inc.
$129
Bayer HealthCare Pharmaceuticals Inc.
$125
IDORSIA PHARMACEUTICALS US INC
$125
Janssen Pharmaceuticals, Inc
$124
Novartis Pharmaceuticals Corporation
$124
Paratek Pharmaceuticals, Inc.
$117
Avadel CNS Pharmaceuticals, LLC
$115
HARMONY BIOSCIENCES LLC
$113
Insmed, Inc.
$101
Shire North American Group Inc
$98
E.R. Squibb & Sons, L.L.C.
$96
Teva Pharmaceuticals USA, Inc.
$62
GENZYME CORPORATION
$53
ZOLL Circulation Inc
$50
Genentech USA, Inc.
$48
Harmony Biosciences LLC
$46
Hikma Pharmaceuticals USA
$32
Electromed, Inc.
$31
Amgen Inc.
$26
Mylan LLC
$25
Baxter Healthcare
$22
Mylan Specialty L.P.
$22
Merck Sharp & Dohme LLC
$20
Takeda Pharmaceuticals U.S.A., Inc.
$19
CSL Behring
$19
Olympus Latin America, Inc.
$15
Philips Electronics North America Corporation
$13
Top 3 companies account for 44.9% of total payments
Associated products mentioned in payments ›
(8874) inCourage · AIRSUPRA · AREXVY · Actemra · Adempas · AirDuo Digihaler · Arikayce · BLUE RHINO · BREZTRI · CHARTIS CATHETER · CUVITRU · DIFICID · DUPIXENT · ELIQUIS · FARXIGA · FASENRA · GIAPREZA · GLASSIA · Hillrom - Monarch Airway Clearance System · IMFINZI · Kcentra · LUMRYZ · NUCALA · NUZYRA · OFEV · OPSUMIT · ORENITRAM · Perforomist · Prolastin-C Liquid · QUVIVIQ · REMODULIN · Ryaltris · SMARTVEST · SPiN Vision Video Processor · STIOLTO RESPIMAT · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · Temperature Management System · UPTRAVI · Wakix · XARELTO · XOLAIR · Xembify · Xolair · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $534 per 100 Medicare services performed
Looking for a pulmonary disease in Kissimmee?
Compare pulmonary diseases in the Kissimmee area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
39
Per 100K population
9.6
County median income
$68,711
Nearest hospital
HCA FLORIDA POINCIANA HOSPITAL
4.1 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ortiz-Bonilla is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ortiz-Bonilla experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Ortiz-Bonilla performed 815 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ortiz-Bonilla receive payments from pharmaceutical companies?
Yes. Dr. Ortiz-Bonilla received a total of $7,079 from 37 companies across 168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ortiz-Bonilla's costs compare to other pulmonary diseases in Kissimmee?
Dr. Ortiz-Bonilla's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ortiz-Bonilla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →